arrow_back Back to App

Enhanced Transparency for Medical Device Risks

This act aims to improve patient safety by providing faster public notification of potential risks associated with medical devices. Citizens will have access to more current and comprehensive risk information, enabling them to make informed treatment decisions. Device manufacturers will have an opportunity to provide input before warnings are published.
Key points
Faster public notification of new, potential risks related to medical devices.
Risk information will be based on credible scientific evidence and include known benefits of the device.
Device manufacturers will have the right to comment on information before public release.
Notifications will be regularly updated, and unconfirmed risks will be rescinded.
Increased transparency regarding third-party data used for medical device decisions.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_7646
Sponsor: Rep. Guthrie, Brett [R-KY-2]
Process start date: 2022-05-03
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Emerging Signals Modernization Act of 2022

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_7646.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-05-03.

What are the main provisions?

Key points include:

  • Faster public notification of new, potential risks related to medical devices.
  • Risk information will be based on credible scientific evidence and include known benefits of the device.
  • Device manufacturers will have the right to comment on information before public release.
  • Notifications will be regularly updated, and unconfirmed risks will be rescinded.
  • Increased transparency regarding third-party data used for medical device decisions.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Guthrie, Brett [R-KY-2].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health